Pneumocystis carinii pleuropneumonia after aerosolized pentamidine prophylaxis
β Scribed by S. Ewig; J. von Kempis; J. Rockstroh; D. Niese; A. Steudel; J. Vogel
- Publisher
- Springer-Verlag
- Year
- 1991
- Tongue
- English
- Weight
- 810 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0300-8126
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The optimal dosage of pentamidine for prophylaxis of Pneumocystis carinii pneumonia (PcP) is unknown. We assessed the effects of 300 mg pentamidine inhaled every 2 weeks. Salbutamol was added for prevention of bronchoconstriction. A total of 128 consecutive HIV patients were enrolled, 21 of whom wer
The incidence of Pneumocystis carinii pneumonia (PCP) and toxoplasmic encephalitis (TE) was analyzed in 83 human immunodeficiency virus (HIV)-infected patients who inhaled aerosolized pentamidine (AP) either for primary prophylaxis (group Ia) or secondary prophylaxis (group IIa) of PCP. These cohort
## Atypical pulmonary manifestations of Pneumocystis carinii infection and fair numbers of extrapulmonary and disseminated infections have lately been documented in patients with human immunodeficiency virus infection treated prophylactically with inhalative pentamidine. We report the case of a 32